Patients receiving chemotherapy in Lincolnshire can now have additional treatment to help reduce their hair loss. Many cancer ...
A study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple ...
Women had a lower probability of receiving any disease-modifying treatment (DMT) and were even less likely to get ...
The online program "Eating Well with MS" improved dietary behavior among multiple sclerosis patients and was deemed valuable, ...
Among 282 patients with pediatric-onset MS, 39% started high-efficacy therapy early (at ages 12-17), and 61% started late ...
Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients, a ...
HealthDay on MSN4d
Some People With MS May Need Earlier, Higher-Dose MedsEarly, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients, a ...
Researchers have identified biomarkers that can predict disease progression in multiple sclerosis, which could lead to the ...
Tolebrutinib delayed the onset of disability progression by 31% for patients with a type of the disease called non-relapsing ...
The positive readout in patients with non-relapsing secondary progressive multiple sclerosis comes on the heels of ...
News Medical on MSN2d
Study reveals biomarkers that predict disability worsening in multiple sclerosisA pioneering study presented today at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple sclerosis (MS).
Sanofi has shared data from the phase 3 HERCULES trial that could rescue its multiple sclerosis (MS) drug candidate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback